Here we performed the first detailed investigation of the effects of a glucagon like peptide-1 receptor (GLP-1R) agonist in lipoatrophic diabetes, using mice with generalised lipodystrophy
Whatever your resolutions are for 2025, I wish you and yours a happy and healthy year
Because these changes occur at different tissue layers, selecting the right treatment requires a careful evaluation of your unique facial structure
Unlike some other secretagogues, it's notable for not significantly affecting cortisol or prolactin pathways in cell-model studies, making it a useful tool for isolating ghrelin-specific signalling
Future research should focus on exploring subtype-specific mechanisms, clinical translation pathways, and combination strategies for expanding their application in solid tumors
Do I Need to Start Again at the Lowest GLP-1 Dose